• Home
  • News
  • Portfolio News
  • Zylö Receives $1,700,000 NIH Phase II Grant to Advance Erectile Dysfunction Program into Human Trials

Zylö Receives $1,700,000 NIH Phase II Grant to Advance Erectile Dysfunction Program into Human Trials

21Jul

Zylö Receives $1,700,000 NIH Phase II Grant to Advance Erectile Dysfunction Program into Human Trials

Portfolio News

Zylö Therapeutics Inc., developer of the transformational Z-pod™ topical delivery platform, has been awarded a $1,700,000 Small Business Innovation Research (SBIR) grant to advance Zylö’s proprietary nitric-oxide-releasing topical drug candidate into clinical trials. Read more >>

Share this post

Related Posts

28Oct

Kalion Inc. Teams with Agile BioFoundry To Win DOE Grant to Advance Bio-based Glucaric Acid

Kalion Inc., along with 8 other companies, was selected by the U.S. Department of Energy to receive $5.7 million in... read more
27Oct

Candidly Expands Beyond Student Debt Solutions with Emergency Savings Solution to Build Financial Resilience

Candidly, the leading AI-driven student debt and savings optimization platform, announced today the launch of its Emergency Savings solution. This... read more
05Dec

Two Babson Alumni Businesses to Appear on ‘Meet the Drapers’—a New TV Show Turning Viewers into Investors

Green Piñata will appear in Episode Four on Sunday, December 10 at 6 p.m. ET. Read more... read more
06Jan

Myomo to Present H.C. Wainwright Virtual BioConnect 2021 Conference

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis,... read more
18Nov

Regroup Mass Notification Partners with Alvarez Associates

Regroup Mass Notification, the award-winning leader in emergency and day-to-day communication technology, today announced joint alliance with Alvarez Associates, an... read more
14Sep

UA scientists invent technology to help legally blind see better

A University of Arizona scientist helped create eyewear technology that is changing the way people with low vision see the... read more
04Jun

Zylö Therapeutics Closes $5.225 Million Series B Financing

Zylö Therapeutics Inc., dedicated to developing a transformational drug-delivery platform, announced that it has raised $5.225 million in its Series... read more
25Feb

SCBIO caps annual conference in Charleston with $5,000 pitch competition

To close out the SCBIO 2023 conference, three South Carolina early startups in the life sciences industry pitched venture capitalists... read more
02Mar

OmniLife Health Survey Shows Rapid Adoption of Clinical Workflow Automation Among U.S. Healthcare Organizations

Healthcare organizations nationwide are increasing their use of clinical workflow automation (CWA) software to enhance productivity, reduce costs and improve... read more
13Jul

Myomo announces center of excellence program

Myomo Inc., a medical robotics company, has created a new program to partner with O&P clinics in the United States... read more